What are the potential stocks in the pharmaceutical blue-chip market?

The following 10 pharmaceutical blue chips can best meet the dual requirements of performance growth and valuation safety, including: Huadong Pharmaceutical, Zhongheng Group, Hualan Bio, Renfu Pharmaceutical, Kangmei Pharmaceutical, Yunnan Baiyao, Dong 'e Ejiao, China Resources Sanjiu, Haizheng Pharmaceutical and Tasly.

Blue chip refers to a stable cash dividend policy, which requires higher cash flow management of the company. Usually, those companies with good business performance and stable and high cash dividend payment are called "blue chips". Blue-chip stocks refer to large, traditional industrial stocks and financial stocks that grow steadily for a long time.

In the stock market, investors refer to the shares of large companies that occupy an important leading position in their respective industries, with excellent performance, active trading and rich dividends as blue chips.

Blue-chip stocks are well-managed, profitable and return to shareholders every year. Such companies have the ability to profit from the prosperity and depression of the industry with less risk.

Excellent performance, stable income, large share capital, rich dividends, stable stock price trend and good market image.

(1) During the depression, the company can make plans and measures to ensure the company's development;

(2) In the prosperous period, the company can exert its greatest ability to create profits;

(3) During the period of inflation, the actual surplus capacity of the company remains unchanged or increases.